Cordlife Group Ltd. (CLIFF)
0.0704
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 18.04M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -39.15% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 0.5251 |
| Price to Book Value | 0.2278 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.043 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 81.69% |
Profile
| Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, cord lining, and tissue services. The Diagnostics segment consists of diagnostic testing services including non-invasive prenatal testing, newborn metabolic screening, and paediatric vision screening services. The company was founded on May 2, 2001 and is headquartered in Singapore. |
| URL | http://www.cordlife.com |
| Investor Relations URL | http://cordlife.listedcompany.com/ |
| HQ State/Province | Central Singapore |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 09, 2022 |
Profile
| Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, cord lining, and tissue services. The Diagnostics segment consists of diagnostic testing services including non-invasive prenatal testing, newborn metabolic screening, and paediatric vision screening services. The company was founded on May 2, 2001 and is headquartered in Singapore. |
| URL | http://www.cordlife.com |
| Investor Relations URL | http://cordlife.listedcompany.com/ |
| HQ State/Province | Central Singapore |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 09, 2022 |